Abstract
Previously, we and others have reported high levels of expression of the c-erbB-2/neu gene in non-small cell lung cancer cell lines and primary tumors. We have also found that expression of c-erbB-2/neu-encoded p185neu was correlated with lymph node metastasis in lung squamous cell carcinomas. To investigate the potential role of the c-erbB-2/neu gene in lung cancer metastasis systematically, we introduced the human c-erbB-2/neu gene into very low p185neu-expressing NCI-H460 human non-small cell lung cancer cells and then examined the experimental metastatic potentials among the parental NCI-H460 cells and stable transfectants with increased expression of p185neu. Compared with the parental NCI-H460 cells, the NCI-H460 transfectants overexpressing p185neu produced significantly more pulmonary and extrapulmonary metastatic tumors in nude mice. The changes in experimental metastatic potential in vivo were accompanied by increased invasiveness in vitro. In addition, important steps in the invasion and metastasis process, such as secretion of basement membrane-degradative enzymes and migration through reconstituted basement membrane (Matrigel), were also increased in the NCI-H460 transfectants overexpressing p185neu. Moreover, scanning electron microscopy revealed that the p185neu-overexpressing NCI-H460 transfectants had significantly more microvilli and membrane protrusions than the parental cells, correlating with the increased invasive properties of these cells. The results demonstrate that overexpression of p185neu can enhance the experimental metastatic potential of NCI-H460 human lung cancer cells by promoting invasion and the other steps in the metastatic cascade.
Footnotes
-
↵1 This research was supported in part by Department of Health and Human Services Cancer Center Core Support Grant P30-CA16672 from the National Cancer Institute.
-
↵2 Supported by Department of Health and Human Services Grant RO3-CA54989 from the National Cancer Institute.
-
↵3 Visiting scientist from the Development Center for Biotechnology, Taipei, Republic of China.
-
↵4 From Chest Department, Veteran's General Hospital-Taipei, Taipei, Republic of China.
-
↵5 Supported by Department of Health and Human Services Grant R35-CA44352 from the National Cancer Institute.
-
↵6 Supported by Department of Health and Human Services Grants RO1-CA58880 and RO1-CA60856 and Grant 0287 from Smokeless Tobacco Research Council, Inc. (to M. C. H.). To whom requests for reprints should be addressed, at the Department of Tumor Biology, Box 79, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.
- Received December 16, 1993.
- Accepted April 14, 1994.
- ©1994 American Association for Cancer Research.